Jane Street
MGRX icon

Jane Street’s Mangoceuticals MGRX Stock Holding History

Jane Street’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.2K Buy
72,746
+25,243
+53% +$12.1K ﹤0.01% 11143
2025
Q4 		$35.2K Buy
+47,503
New +$77K ﹤0.01% 10605

Other funds holding MGRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $488M AUM 14.36% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street's MGRX Position: Q1 2026 in Review

Jane Street increased its Mangoceuticals (MGRX) stake by 53% in Q1 2026, buying an estimated $12.1K and bringing the position to 72,746 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #11143.

Jane Street first reported a position in MGRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $35.2K in Q4 2025. 18 funds tracked by Wall St. Rank hold MGRX as of Q1 2026.

  • Jane Street held 72,746 shares of Mangoceuticals worth $26.2K as of Q1 2026.
  • Jane Street bought 25,243 Mangoceuticals shares in Q1 2026, an estimated $12.1K.
  • Mangoceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11143 holding.
  • Jane Street first reported a position in Mangoceuticals in Q4 2025 and has held it in 2 quarters since.
  • Jane Street's Mangoceuticals position peaked at $35.2K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.